| Status | Acronym | ISRCTN | EudraCT | NCT (clinicaltrials.gov) | DRKS |
|---|---|---|---|---|---|
| Planned (Transit Ethics), pub. | SARS-CoV-2CP-HD-001 | 2020-001632-10 |
A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease
Purpose / Objectives
Diagnosis
- COVID-19 infection
Study design
- Phase II
- Prospective
- Two-arm
- Open Label
- Randomized
- Cross-over
Documents (password protected)
Go to download area (no documents yet)
Responsibilities in overall study
Sponsor
Ruprecht-Karls-Universität Heidelberg
- Tel. +49 6221 54-0
- Fax +49 6221 54-2618
- forschungsdezernat@zuv.uni-heidelberg.de
(National) Coordinating Investigator
Prof. Dr. Carsten Müller-Tidow